271
Views
2
CrossRef citations to date
0
Altmetric
Acne

Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT)

, , &
Pages 272-274 | Received 25 Oct 2011, Accepted 16 Dec 2011, Published online: 11 Jan 2012

References

  • Katsambas AD, Stefanaki CS, Cunliffe WJ. Guidelines for treating acne. Clin Dermatol. 2004;22:439–444.
  • Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008;27:197–206.
  • Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology. 2002;204:232–235.
  • Zane LT, Leyden WA, Marqueling AL, Manos M. A Population-Based Analysis of Laboratory Abnormalities During Isotretinoin Therapy for Acne Vulgaris. Arch Dermatol. 2006;142:1016–1022.
  • Alcalay J, Landau M, Zucker A. Analysis of laboratory data in acne patients treated with isotreinoin: is there really a need to perform routine laboratory tests? J Dermatolog Treat. 2001;12:9–12.
  • Ertam I, Alper S, Unal I. Is it necessary to have routine blood tests in patients treated with isotretinoin? J Dermatolog Treat. 2006;17:214–216.
  • Dootson GM, Keidan J, Anderson JAR. Exacerbation of bleeding tendency in a patient with haemophilia A, during treatment with isotretinoin. Br J dermatol. 1992;127:186–187.
  • Bettoli V, Pizzigoni S, Vasina S, Mancino A, Virgili A. Oral isotretinoin and haemophilia A. J Eur Acad Dermatol Venereol. 2004;18:718–720.
  • Hesdorffer CS, Weltman MD, Raftopoulos H, Mendelow B, Bezwoda WR. Thrombocytopenia caused by isotretinoin. S Afr Med J. 1986;70:705–706.
  • Johnson TM, Rapini RP. Isotretinoin-induced thrombocytopenia. J Am Acad Dermatol. 1987;17:838–839.
  • Aurousseau MH, Levacher S, Bénéton C, Blaise M. Pourriat JL. Transient dysfibrinogenemia and thrombocytopenia associated with recurrent acute pancreatitis in the course of isotretinoin therapy. Rev Med Interne. 1995;16:622–625.
  • Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother. 2003;37:1622–1624.
  • Labiris G, Katsanos A, Karapetsa M, Mpanaka I, Chatzoulis D. Association between isotretinoin use and central retinal vein occlusion in an adolescent with minor predisposition for thrombotic incidents: a case report. J Med Case Reports. 2009;3:58.
  • Laroche ML, Macian-Montoro F, Merle L, Vallat JM. Cerebral ischemia probably related to isotretinoin. Ann Pharmacother. 2007;41:1073–1076.
  • Whitman MC, Walker DM. A case of lower extremity venous thrombosis in the pediatric emergency department: associations with May-Thurner syndrome and ısotretinoin use. Pediatr Emerg Care. 2011;27:125–128.
  • Wallnöfer AE, Van Griensven JM, Schoemaker HC, Cohen AF, Lambert W, Kluft C, et al. Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans. Thromb Haemost. 1993;70:1005–1008.
  • Dootson GM, Keidan J, Harper PL. The influence of isotretinoin upon fibrinolysis in patients with acne. Br J Dermatol. 1995;133:66–70.
  • Bäck O, Nilsson TK. Retinoids and fibrinolysis. Acta Derm Venereol. 1995;75:290–292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.